DrugPatentWatch Database Preview
Betrixaban - Generic Drug Details
» See Plans and Pricing
What are the generic sources for betrixaban and what is the scope of freedom to operate?
Betrixaban
is the generic ingredient in one branded drug marketed by Portola Pharms Inc and is included in one NDA. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.Betrixaban has one hundred and twenty-seven patent family members in thirty-two countries.
Summary for betrixaban
International Patents: | 127 |
US Patents: | 10 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Bulk Api Vendors: | 69 |
Clinical Trials: | 9 |
Patent Applications: | 788 |
Formulation / Manufacturing: | see details |
DailyMed Link: | betrixaban at DailyMed |
Recent Clinical Trials for betrixaban
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Portola Pharmaceuticals | Phase 3 |
Merck Sharp & Dohme Corp. | Phase 2 |
Merck Sharp & Dohme Corp. | Phase 1 |
US Patents and Regulatory Information for betrixaban
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Y | Y | Start Trial | ||
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Y | Y | Start Trial | ||
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Y | Y | Start Trial | ||
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Y | Y | Start Trial | ||
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | DISCN | Yes | No | Start Trial | Start Trial | Y | Y | Start Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for betrixaban
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | Start Trial | Start Trial |
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | Start Trial | Start Trial |
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | Start Trial | Start Trial |
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | Start Trial | Start Trial |
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | Start Trial | Start Trial |
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | Start Trial | Start Trial |
Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for betrixaban
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 2627086 | Start Trial |
European Patent Office | 2513058 | Start Trial |
Taiwan | I443088 | Start Trial |
Japan | 2013514380 | Start Trial |
New Zealand | 592533 | Start Trial |
World Intellectual Property Organization (WIPO) | 2008073670 | Start Trial |
Japan | 2003509406 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |